Literature DB >> 36160077

The Effects of 6q26-q27 Terminal Deletion on Intellectual Disability & Brain Malformations and the Genotype/Phenotype Relationship: A Case Report.

Veysel Özdağ1, Yaşar Tanir1.   

Abstract

Terminal microdeletion of chromosome 6q is a rare syndrome that can result in a spectrum of phenotypes varying from normal intelligence-minimal clinical symptoms to severe neurological defects and developmental delays. The most frequent clinical characteristics include developmental delays prior to and following birth as well as intellectual disability, brain malformations, and facial dysmorphism. These clinical characteristics may not be correlated with the size of the deletion; as many cases have been identified with either minor or major deletions, the genotype-phenotype correlation should be better investigated. To our knowledge, this is the first report of 6q26-q27 chromosome microdeletion in Turkey. In this article, we determine the clinical and genomic characteristics of a 2-year-old female case of 6q26-q27 chromosome microdeletion by investigating the level of development of the patient, brain malformations and dysmorphic characteristics, and ultimately comparing them to other cases reported in literature. Our patient was diagnosed with severe Global Developmental Delays (GDD). Although our case had similar clinical characteristics to corresponding cases in literature, there is a difference in the variety and group of symptoms exhibited. Copyright:
© 2022 Turkish Neuropsychiatric Society.

Entities:  

Keywords:  6q26-q27 microdeletion; global developmental delay; intellectual disability

Year:  2022        PMID: 36160077      PMCID: PMC9466636          DOI: 10.29399/npa.27797

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.066


  17 in total

1.  Cytogenetic and array-CGH characterization of a 6q27 deletion in a patient with developmental delay and features of Ehlers-Danlos syndrome.

Authors:  A L Mosca; P Callier; A Masurel-Paulet; C Thauvin-Robinet; N Marle; M Nouchy; F Huet; D Dipanda; A De Paepe; P Coucke; F Mugneret; L Faivre
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

Review 2.  Genomic detection of a familial 382 Kb 6q27 deletion in a fetus with isolated severe ventriculomegaly and her affected mother.

Authors:  Mili Thakur; Elena Bronshtein; Michael Hankerd; Henry Adekola; Karoline Puder; Bernard Gonik; Salah Ebrahim
Journal:  Am J Med Genet A       Date:  2018-09-08       Impact factor: 2.802

Review 3.  A clinical approach to developmental delay and intellectual disability.

Authors:  Pradeep Vasudevan; Mohnish Suri
Journal:  Clin Med (Lond)       Date:  2017-12       Impact factor: 2.659

4.  TBP as a candidate gene for mental retardation in patients with subtelomeric 6q deletions.

Authors:  Liesbeth Rooms; Edwin Reyniers; Stefaan Scheers; Rob van Luijk; Jan Wauters; Leen Van Aerschot; Zsuzsanna Callaerts-Vegh; Rudi D'Hooge; Gabrielle Mengus; Irwin Davidson; Winnie Courtens; R Frank Kooy
Journal:  Eur J Hum Genet       Date:  2006-06-14       Impact factor: 4.246

5.  PARK2 copy number aberrations in two children presenting with autism spectrum disorder: further support of an association and possible evidence for a new microdeletion/microduplication syndrome.

Authors:  Angela Scheuerle; Kathleen Wilson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-02-25       Impact factor: 3.568

6.  Replication dynamics at common fragile site FRA6E.

Authors:  Elisa Palumbo; Laura Matricardi; Elena Tosoni; Aaron Bensimon; Antonella Russo
Journal:  Chromosoma       Date:  2010-06-29       Impact factor: 4.316

7.  Relative impact of nucleotide and copy number variation on gene expression phenotypes.

Authors:  Barbara E Stranger; Matthew S Forrest; Mark Dunning; Catherine E Ingle; Claude Beazley; Natalie Thorne; Richard Redon; Christine P Bird; Anna de Grassi; Charles Lee; Chris Tyler-Smith; Nigel Carter; Stephen W Scherer; Simon Tavaré; Panagiotis Deloukas; Matthew E Hurles; Emmanouil T Dermitzakis
Journal:  Science       Date:  2007-02-09       Impact factor: 47.728

8.  Periventricular heterotopia in 6q terminal deletion syndrome: role of the C6orf70 gene.

Authors:  Valerio Conti; Aurelie Carabalona; Emilie Pallesi-Pocachard; Elena Parrini; Richard J Leventer; Emmanuelle Buhler; George McGillivray; François J Michel; Pasquale Striano; Davide Mei; Françoise Watrin; Stefano Lise; Alistair T Pagnamenta; Jenny C Taylor; Usha Kini; Jill Clayton-Smith; Francesca Novara; Orsetta Zuffardi; William B Dobyns; Ingrid E Scheffer; Stephen P Robertson; Samuel F Berkovic; Alfonso Represa; David A Keays; Carlos Cardoso; Renzo Guerrini
Journal:  Brain       Date:  2013-09-20       Impact factor: 13.501

9.  A copy number variation morbidity map of developmental delay.

Authors:  Gregory M Cooper; Bradley P Coe; Santhosh Girirajan; Jill A Rosenfeld; Tiffany H Vu; Carl Baker; Charles Williams; Heather Stalker; Rizwan Hamid; Vickie Hannig; Hoda Abdel-Hamid; Patricia Bader; Elizabeth McCracken; Dmitriy Niyazov; Kathleen Leppig; Heidi Thiese; Marybeth Hummel; Nora Alexander; Jerome Gorski; Jennifer Kussmann; Vandana Shashi; Krys Johnson; Catherine Rehder; Blake C Ballif; Lisa G Shaffer; Evan E Eichler
Journal:  Nat Genet       Date:  2011-08-14       Impact factor: 38.330

10.  Delineation variable genotype/phenotype correlations of 6q27 terminal deletion derived from dic(6;18)(q27;p10).

Authors:  Lili Zhou; Chong Chen; Huanzheng Li; Yunying Chen; Xueqin Xu; Xiaoling Lin; Shaohua Tang
Journal:  Mol Cytogenet       Date:  2014-11-14       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.